Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy.
Patients affected by X-linked adrenoleukodystrophy (X-ALD) present a progressive brain and peripheral demyelination and adrenal cortex insufficiency, associated with accumulation of the very long chain fatty acids (VLCFA) hexacosanoic acid (C26:0) and tetracosanoic acid (C24:0) in different tissues and biological fluids. X-ALD is characterized by heterogeneous clinical phenotypes. Seven clinical variants have been described for this genetic disorder, being the childhood cerebral form (CCER), adrenomyeloneuropathy (AMN) and asymptomatic the most common clinical forms. In a previous work, we showed evidence that oxidative stress is involved in the pathophysiology of X-ALD symptomatic patients. In the present study, we compared oxidative stress parameters, namely thiobarbituric acid reactive substances (TBA-RS) and total antioxidant status (TAS), in plasma from patients with CCER, AMN and in asymptomatic X-ALD patients. It was observed that symptomatic and asymptomatic X-ALD patients presented a significant increase of plasma TBA-RS measurement, indicating a stimulation of lipid peroxidation. Furthermore, lipid peroxidation was higher in AMN, as compared to CCER and asymptomatic patients. We also observed that the total antioxidant defenses (TAS) were decreased in symptomatic but not in asymptomatic X-ALD patients. Therefore, it may be presumed that asymptomatic patients seem to be protected against oxidative stress because of their normal antioxidant defenses and that other factors besides oxidative damage may be responsible for the severity of the symptoms in X-ALD and need to be investigated.
Deon
Marion
M
Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil. marion_deon@yahoo.com.br
Sitta
Angela
A
Barschak
Alethea G
AG
Coelho
Daniela M
DM
Pigatto
Maiara
M
Schmitt
Graziela O
GO
Jardim
Laura B
LB
Giugliani
Roberto
R
Wajner
Moacir
M
Vargas
Carmen R
CR
D000326:Adrenoleukodystrophy / Q000378:metabolism*; D000975:Antioxidants / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D006801:Humans; D007202:Indicators and Reagents; D015227:Lipid Peroxidation / Q000502:physiology*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
D000975:Antioxidants; D001798:Blood Proteins; D007202:Indicators and Reagents; D017392:Thiobarbituric Acid Reactive Substances